NO127194B - - Google Patents

Download PDF

Info

Publication number
NO127194B
NO127194B NO01721/68A NO172168A NO127194B NO 127194 B NO127194 B NO 127194B NO 01721/68 A NO01721/68 A NO 01721/68A NO 172168 A NO172168 A NO 172168A NO 127194 B NO127194 B NO 127194B
Authority
NO
Norway
Prior art keywords
methyl
acid
hydroxyprogesterone
analogous method
diol
Prior art date
Application number
NO01721/68A
Other languages
Norwegian (no)
Inventor
Klaus Prezewowsky
Friedmund Neumann
Rudolf Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO127194B publication Critical patent/NO127194B/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)

Description

Analogifremgangsmåte ved fremstilling av farmakologisk Analogy method in the preparation of pharmacological

aktive 18-methyl-19-nor-17a-hydroxyprogesteroner og deres active 18-methyl-19-nor-17a-hydroxyprogesterones and their

estere. esters.

Foreliggende oppfinnelse angår en analogifremgangsmåte ved fremstilling av nye l8-methyl-19-nor-17a-hydroxyprogesteroner og deres -17-estere av den generelle formel The present invention relates to an analogous process for the production of new 18-methyl-19-nor-17a-hydroxyprogesterones and their -17-esters of the general formula

hvor R betegner hydrogen eller en acylrest med 1-11 C-atomer i esterresten, og C^ :.... Cy betegner en enkelt eller dobbelt carbon-carbon-binding, hvilken fremgangsmåte utmerker seg ved at man reduserer l8-methyl-19-nor-A^'^-pregnatrien-3,17a-diol-20-on-3-alkylether-20-ketal etter Birch i flytende ammoniakk eller elektrolytisk i organisk løsningsmiddel, hydrolyserer primærproduktet i surt miljo og eventuelt deretter omsetter det således erholdte l8-methyl-19-nor-17a-hydroxyprogesteron med en onsket syre eller et reaktivt syrederivat til -17-esteren og om onskes innforer en dobbeltbinding i 6,7-stillingen. where R denotes hydrogen or an acyl residue with 1-11 C atoms in the ester residue, and C^ :.... Cy denotes a single or double carbon-carbon bond, which method is distinguished by reducing l8-methyl-19 -nor-A^'^-pregnatriene-3,17a-diol-20-one-3-alkylether-20-ketal according to Birch in liquid ammonia or electrolytically in an organic solvent, hydrolyzes the primary product in an acidic environment and optionally then converts the thus obtained 18-methyl-19-nor-17a-hydroxyprogesterone with a desired acid or a reactive acid derivative to the -17-ester and, if desired, introduces a double bond at the 6,7-position.

Alkylgruppen i ethergruppen i utgangsmaterialets 3-stilling er en lavere alkylgruppe, fortrinnsvis -CH^ eller -C2H,-. The alkyl group in the ether group in the 3-position of the starting material is a lower alkyl group, preferably -CH 2 or -C 2 H 2 -.

De fremstilte forbindelser har overraskende sterk gestagen virk-ning. Det var uventet at disse forbindelser, representert ved 18-mefhyl-19-nor-17a-hydroxyprogesteron-17-acetat (VI) og 18-methyl-19-nor-17a-hydroxyprogesteron (VII), skulle vise seg å være bedre enn f.eks. de kjente, allerede sterkt gestagent virksomme forbindelser I-V, som vist i den nedenstående tabell. Forsøksresultatene ble oppnådd ved subcutan administrering i oljeopplosning på kaniner i den vanlige Clauberg-test,idet McPhail-indeksen ble benyttet som sammenligningsverdi. The compounds produced have a surprisingly strong progestagen effect. It was unexpected that these compounds, represented by 18-methyl-19-nor-17a-hydroxyprogesterone-17-acetate (VI) and 18-methyl-19-nor-17a-hydroxyprogesterone (VII), should prove to be better than e.g. the known, already highly progestogenic compounds I-V, as shown in the table below. The test results were obtained by subcutaneous administration in oil solution to rabbits in the usual Clauberg test, with the McPhail index being used as a comparison value.

For praktisk anvendelse, f.esk. i gestagenterapien, blandes de nye aktive forbindelser med de i den galeniske farmasi vanlige bærermaterialer og overfores til de vanlige administreringsformer, såsom tabletter, dragéer, kapsler, injeksjonsopplbsninger, o.s.v. For practical use, e.g. in progestagen therapy, the new active compounds are mixed with the usual carrier materials in galenic pharmacy and transferred to the usual administration forms, such as tablets, dragees, capsules, injection solutions, etc.

Fremstillingen av de nye forbindelser utfores etter i og for seg kjente arbeidsmetoder. For reduksjon av den aromatiske A-ring egner seg foruten den alminnelig kjente kjemiske reduksjon etter Birch i flytende ammoniakk med fortrinnsvis lithium(også elektrolytisk reduksjon i egnet opplosningsmiddel og i'nærvær av elektrolytsalter. The production of the new compounds is carried out according to work methods known per se. For the reduction of the aromatic A ring, in addition to the commonly known chemical reduction according to Birch in liquid ammonia with preferably lithium, electrolytic reduction in a suitable solvent and in the presence of electrolyte salts is also suitable.

Opplosningsmidler som egner seg for anvendelse under elektro-lysen, er fortrinnsvis primære eller tertiære alkylaminer eller også alifatiske aminer med flere aminogrupper. Særlig egnede er methylamin, ethylamin og ethylendiamin. Dersom opplbsligheten av det som utgangsmaterial anvendte steroid er for liten i de nevnte baser, kan reaksjonsblandingen også tilsettes opplosningsmidler, f.eks. ethere såsom tetrahydrofuran, som hjelpeopplosningsmiddel. Solvents suitable for use during the electrolysis are preferably primary or tertiary alkylamines or also aliphatic amines with several amino groups. Particularly suitable are methylamine, ethylamine and ethylenediamine. If the solubility of the steroid used as starting material is too small in the aforementioned bases, solvents can also be added to the reaction mixture, e.g. ethers such as tetrahydrofuran, as co-solvent.

Som elektrolytsalter anvendes slike s.&lter som dissosierer godt i de anvendte opplosningsmidler eller opplosningsmiddelblandinger. Særlige egnede er alkalimetall- og jordalkalimetallhalogenider, såsom lithiumklorid, kaliumjodid, kalsiumjodid, o.s.v. As electrolyte salts, such salts are used which dissociate well in the solvents or solvent mixtures used. Particularly suitable are alkali metal and alkaline earth metal halides, such as lithium chloride, potassium iodide, calcium iodide, etc.

Den ved kjemisk eller elektrolytisk reduksjon primært erholdte 20-ketal av A ' -3-alkyletheren hydrolyseres på vanlig måte til l8-methyl-19-nor-17a-hydroxyprogesteron, fortrinnsvis med sterk syre. The 20-ketal of the A'-3-alkyl ether obtained primarily by chemical or electrolytic reduction is hydrolyzed in the usual way to 18-methyl-19-nor-17a-hydroxyprogesterone, preferably with a strong acid.

Den eventuelt påfolgende forestring utfores etter konvensjon-elle metoder. Eksempelvis kan nevnes omsetning med anhydridet eller syrehalogenidet av den bsnkede syre i nærvær av sure eller basiske reagenser, eller forestring av den onskede syre i nærvær av trifluoreddiksyreanhydrid. Any subsequent esterification is carried out according to conventional methods. Examples include reaction with the anhydride or acid halide of the base acid in the presence of acidic or basic reagents, or esterification of the desired acid in the presence of trifluoroacetic anhydride.

Syrer som kan anvendes ved forestringen, er alle de syrer som Acids that can be used in the esterification are all acids which

er anvendbare i steroidkjemien. Foretrukne syrer er alifatiske carboxylsyrer, med fra 1 til 11 carbonatomer i syreradikalet, såsom f.eks. eddiksyre, propionsyre, capronsyre, enanthsyre, undecylsyre, o.s.v. Selvfølgelig kan syrene også være umettede, forgrenede, flerbasiske eller substituert på vanlig måte. Eksempelvis kan nevnes trimethyl-, dimethyl-,diethyl-. og t.butyleddiksyre, 2,2-dimethyl-smorsyre, fenyl- eller cyclohexyleddiksyre, cyclopentylpropionsyre, halogeneddiksyre, aminoeddiksyre, oxypropionsyre, benzoesyre, ravsyre og adipinsyre. are applicable in steroid chemistry. Preferred acids are aliphatic carboxylic acids, with from 1 to 11 carbon atoms in the acid radical, such as e.g. acetic acid, propionic acid, caproic acid, enanthic acid, undecyl acid, etc. Of course, the acids can also be unsaturated, branched, polybasic or substituted in the usual way. Examples include trimethyl-, dimethyl-, diethyl-. and t-butylacetic acid, 2,2-dimethylbutyric acid, phenyl or cyclohexylacetic acid, cyclopentylpropionic acid, haloacetic acid, aminoacetic acid, oxypropionic acid, benzoic acid, succinic acid and adipic acid.

Den eventuelt derpå folgende innforing av A^-dobbeltbindingen utfores likeledes på i og for seg kjent måte. Som dehydreringsmiddel kan f.eks. anvendes kloranil eller 2,5-diklor-5,6-dicyan-benzokinon. The possibly subsequent introduction of the A^ double bond is likewise carried out in a manner known per se. As a dehydrating agent, e.g. chloranil or 2,5-dichloro-5,6-dicyano-benzoquinone are used.

Innføringen av A^-dobbeltbindingen kan imidlertid også utfores på However, the introduction of the A^ double bond can also be carried out on

kjent måte over A^'^-3-alkyletheren med avspaltning av et i 6-stil- known manner over the A^'^-3-alkyl ether with cleavage of an in 6-style

lingen innfort halogenatom. ling introduced halogen atom.

Den ved fremgangsmåten ifolge oppfinnelsen som utgangsmateriale anvendte 20,20-ethy lendioxy-l8-methy 1-19-nor-A1' 3»5 (10) _pregna-trien-3,17a-diol-3-methyletner er likeledes ny og kan fremstilles etter den fdlgende, i og for seg kjente métode: 17a-ethinyl-l8-methyl-A<1>'<3>'<5>^<10>^-estratrien-3,17p,diol-3 met-hylether (smeltepunkt 99>5 - 102°C; fremstilt ut fra 3-methoxy-l8-methy1-1,35(10)-estratrien-17p-ol- ved oxydasjon med kromsyre og omsetning av det erholdte 17-keton med smeltepunkt 144 - l45°C i ethylendiamin med acetylen i nærvær av opplost lithium) fåes ved inn- The 20,20-ethylenedioxy-18-methyl 1-19-nor-A1' 3»5 (10)_pregna-trien-3,17a-diol-3-methylethene used as starting material in the process according to the invention is likewise new and can is prepared according to the following, per se known method: 17a-ethynyl-18-methyl-A<1>'<3>'<5>^<10>^-estratriene-3,17p,diol-3 methyl ether (melting point 99>5 - 102°C; prepared from 3-methoxy-18-methyl-1,35(10)-estratrien-17p-ol- by oxidation with chromic acid and reaction of the obtained 17-ketone with melting point 144 - l45°C in ethylenediamine with acetylene in the presence of dissolved lithium) is obtained by in-

virkning av POCl^ (8 timer ved 70°C ) i nærvær av 2,4-lutidin-17-ethi-nyl-18-methyl-A2 »3»5(10),16_estratraen_3_0i_3_methyletner (smelte- effect of POCl^ (8 hours at 70°C ) in the presence of 2,4-lutidin-17-ethi-nyl-18-methyl-A2 »3»5(10),16_estratraen_3_0i_3_methylethne (melt-

punkt 94 - 96°C), som ved addisjon av vann til ethinylgruppen og epoxydering av A^-dobbeltbindingen mec] H202/NaOH overfores til 16a, 17a-oxido-l8-methyl-19-nor-A1'^'^ (10)-pregnatrien-3-ol-20-on-3-methylether (smeltepunkt 109 - HO°C) over 18-methy1-19-nor-Al,3,5(10),<lD_>pregnatetraen_3_oi_20-on-3-methylether (142,5 -l43,5°C). point 94 - 96°C), which by addition of water to the ethynyl group and epoxidation of the A^-double bond mec] H202/NaOH is transferred to 16a, 17a-oxido-18-methyl-19-nor-A1'^'^ (10 )-pregnatrien-3-ol-20-on-3-methylether (m.p. 109 - HO°C) over 18-methy1-19-nor-Al,3,5(10),<lD_>pregnatetraen_3_oi_20-on-3- methyl ether (142.5 - 143.5°C).

For innforing av 17a-hydroxygruppen åpnes oxidoringen med HBr/is- For the introduction of the 17a-hydroxy group, the oxidation ring is opened with HBr/ice-

eddik, hvoretter det samtidig innforte 16-bromatom fjernes reduk- vinegar, after which the simultaneously introduced 16-bromo atom is removed by reduction

tivt i nærvær av palladium og carbon. 20-ketogruppen i den således erholdte l8-methy1-19-nor-A1'^'^ ^10^-pregnatrien-3,1/a-diol-20-on-3-methylether (smeltepunkt 1/5 - 1/6,5°C) ketaliseres deretter til slutt med ethylenglycol på vanlig måte. tive in the presence of palladium and carbon. The 20-keto group in the 18-methyl-19-nor-A1'^'^ ^10^-pregnatrien-3,1/a-diol-20-one-3-methylether thus obtained (melting point 1/5 - 1/6 .5°C) is then finally ketalized with ethylene glycol in the usual way.

Eksempel 1 Example 1

I 600 ml flytende amoniakk tildryppes langsomt ved -70°C en opplosning av 6 g 20,20,ethylendioxy-18-methy1-19-nor-A<1>'^'^(10)-pregnatrien-3,17a-diol-3-methylether i 350 ml tetrahydrofuran, hvor- A solution of 6 g of 20,20,ethylenedioxy-18-methy1-19-nor-A<1>'^'^(10)-pregnatriene-3,17a-diol is slowly added dropwise at -70°C to 600 ml of liquid ammonia -3-methyl ether in 350 ml of tetrahydrofuran, where-

etter det spyles med 250 ml absolutt tetrahydrofuran. Etter endt tilsetning tilfores porsjonsvis 6 g lithium, hvoretter reaksjonsblandin- after that it is flushed with 250 ml of absolute tetrahydrofuran. After the addition is complete, add 6 g of lithium in portions, after which the reaction mix-

gen omrdres i 2 timer ved en temperatur fra -60° til -50°C, av-farves ved forsiktig tilsetning av 24o ml ethanol og deretter til-/..i is rotated for 2 hours at a temperature from -60° to -50°C, de-coloured by the careful addition of 240 ml of ethanol and then added

lates å oppvarmes til romtemperatur. Deretter opptas blandingen i methylenklorid, og den organiske fase vaskes fioyTral med vann. Den over natriumsulfat torrede opplosning inndampes i vakuum under nitrogenatmosfære. Det tilbakeblivende residuum opploses i en blanding av 200 ml methanol og 40 ml methylenklorid, og oppløsningen tilsettes allowed to warm to room temperature. The mixture is then taken up in methylene chloride, and the organic phase is washed thoroughly with water. The solution dried over sodium sulfate is evaporated in vacuo under a nitrogen atmosphere. The remaining residue is dissolved in a mixture of 200 ml of methanol and 40 ml of methylene chloride, and the solution is added

3o ml konsentrert saltsyre og 55 ml isvann og omrores i to timer ved 40°C. Deretter fortynnes blandingen med vann og ekstraheres med methylenklorid, og den organiske fase vaskes med vann, natriumbi-carbonatopplbsning og deretter på ny med vann til noytral reaksjon og torres over na triumsulfat. Opplosningsmiddelet avdestilleres, og re- 30 ml of concentrated hydrochloric acid and 55 ml of ice water and stirred for two hours at 40°C. The mixture is then diluted with water and extracted with methylene chloride, and the organic phase is washed with water, sodium bicarbonate solution and then again with water to a neutral reaction and dried over sodium sulfate. The solvent is distilled off, and re-

siduet omkrystalliseres fra ethylacetat over carbon. Det erholdes 3,25 g 18-methy1-19-nor-A^-pregnen-17a-ol-3,20-dion. Smeltepunkt 216-217°C; UV (methanol): e2/+0 = lb oOO. the side is recrystallized from ethyl acetate over carbon. 3.25 g of 18-methyl-19-nor-α-pregnen-17α-ol-3,20-dione are obtained. Melting point 216-217°C; UV (methanol): e2/+0 = lb oOO.

Eksempel 2 Example 2

Til en blanding av 0,3b ml iseddik og 2,5 ml absolutt benzen To a mixture of 0.3b ml of glacial acetic acid and 2.5 ml of absolute benzene

tilsettes ved 0°C 0,63 ml trifluoreddiksyreanhydrid. Etter 10 minutter tilsettes denne opplosning 1,05 9 lo-methy1-lo-nor-A 4-pregnen-17a-ol-3,20-dion, og blandingen omrores i 3 timer ved romtemperatur under nitrogenatmosfære og deretter i 2 timer ved b0°C. Etter til- 0.63 ml of trifluoroacetic anhydride is added at 0°C. After 10 minutes, 1.05 9 lo-methy1-lo-nor-A 4-pregnen-17a-ol-3,20-dione is added to this solution, and the mixture is stirred for 3 hours at room temperature under a nitrogen atmosphere and then for 2 hours at b0 °C. After to-

setning av 1 ml methanol inndampes blandingen til tbrrhet, hvoretter residuet tilsettes 1,5 ml methanolisk saltsyre (lOO ml methanol inne- addition of 1 ml of methanol, the mixture is evaporated to dryness, after which 1.5 ml of methanolic hydrochloric acid is added to the residue (100 ml of methanol in

holdende 0,6 ml konsentrert saltsyre), og blandingen oppvarmes ved kokepunktet i 45 minutter. Etter avkjbling fortynnes blandingen med vann, hvoretter substansen ekstraheres med ether og de organiske ekstrakter vaskes til noytral reaksjon med vann og natriumdicarbonat-opplosning. Etter torring over natriumsulfat og avdestillering av opplosningsmiddelet kromatograferes råproduktet over 20 g kiselsyre- containing 0.6 ml of concentrated hydrochloric acid), and the mixture is heated at boiling point for 45 minutes. After cooling, the mixture is diluted with water, after which the substance is extracted with ether and the organic extracts are washed to a neutral reaction with water and sodium bicarbonate solution. After drying over sodium sulfate and distilling off the solvent, the crude product is chromatographed over 20 g of silicic acid

gel (deaktivert med 10 % vann), med petrolether/acéton (fra O % til 20 % aceton). Det erholdes 525 mg 18-methy1-19-nor-A^-pregnen-17a-ol-3,20-dion-17-acetat. Smeltepunkt 210-212°C (fra aceton/hexan ); UV gel (deactivated with 10% water), with petroleum ether/acetone (from 0% to 20% acetone). 525 mg of 18-methyl-19-nor-α-pregnen-17α-ol-3,20-dione-17-acetate are obtained. Melting point 210-212°C (from acetone/hexane); UV

(methanol): ^40 = 1^ 10°*;Eksempel 3 <->■<-->;En blanding av 5 g ltt-methyl-19-nor-A^-pregnen-17a-pl-3,20-dion-17-acetat og IO g kloranil i 125 ml ethylacetat og 25 mlliseddik I, oppvarmes ved kokepunktet i 20 timer under nitrogenatmosfærÆViiÆtter avkjoling fortynnes blandingen med ether og deret ter méd V"4jÉB g^Bgar-etter den vaskes med 1 %-ig natronlut inntil den organiske fase er blitt farvelos. Etter torring over natriumsulfat og fjerning av opplosningsmiddelet kromatograferes residuet over kiselsyregel. Det .er- ;holdes 2,3 g ltt-methyl-19-npr-A^'<6->pregnadien-l-7a-ol-3v20-df^rl7-acetat. ' Illist f ;Eksempel 4 ;Til en opplosning av 4,7 g l8-methyl-19-nor-A^-pregnen-lJg-ol-3,20-dion-17-acetat i 25 ml abs. dioxan tilsettes under omroring 4 ml orthomaursyreethylester og 1 ml av en opplosning av 2,5 ml kons. svovelsyre i JO ml abs. dioxan. Etter 30 minutters omroring ved romtemperatur tilsettes reaksjonsblandingen med 1 ml abs. pyridin, hvoretter blandingen inndampes i en roterende inndamper og residuet tri-tureres med syrefri methanol. Produktet renses ved omkrystallisering fra methanol/methylenklorid. Det erholdes 4 g lS-methy1-19-nor-A^'^-pregnadien-3,17a-diol-20-on-3-ethylether-17a-acetat. ;En blanding av 86 ml aceton, 0,6 ml pyridin, 2,7 g natriumace-tat, 27 ml vann og 4,5 9 18-methy1-19-nor- åJ' -pregnadien-3,17a-diol-20-on-3-ethylether-17a-acetat kjoles til -5°C og tilsettes i lopet av 20 minutter og grundig omroring 2,2 g N-bromsuccinimid og 2,7 ml iseddik. Etter 1 1/2 times omroring under opprettsholdelse av tempera-turen i området fra 0° til -5°C ekstraheres det med ether, hvoretter den organiske fase vaskes til noytral reaksjon med vann og torres. Opplosningen av 6a-brom-18-methy1-19-nor-A^-pregnen-1/a-ol-3,20-dion-17- acetat i ether inndampes i vakuum til et lite volum ved en temperatur under 20°C, hvoretter den tilsettes 70 ml dimethylformamid, 15 g kalsiumcarbonat og 7 9 lithiumbromid. Det blåses nitrogen gjennom opp-løsningen^ og denne oppvarmes noe for å avdrive rester av ether. Til slutt oppvarmes blandingen i en halv time ved 120°C under omroring og under nitrogenatmosfære. Deretter frafiltreres kalsiumcarbonatet varmt ved hjelp av et filter av sintret glass, hvoretter den faste rest vaskes med varmt dimethylformamid og filtratene slås sammen og helles over i isvann. Etter nøytralisering av vannutfeiningen med svovelsyre frafiltreres utfelningen. Residuet oppløses i methylenklorid og opplosningen vaskes med vann og torres. Etter avdestillering av opplosningsmiddelet kromatograferes det erholdte råprodukt over kiselsyregel. Det erholdes 2,5 g lb-me thy 1 - 19-nor-H^ ' <3-pregnadien-17a-ol-3,2o-dion-17-acetat. ;Eksempel 5 ;Ut fra 700 ml l8-methyl-19-nor-A^-pregnen-17a-ol-3,20-dion, 0,456 ml capronsyre og 0,42 ml trifluoreddiksyreanhydrid i 2,5 ml. abs. benzen fremstilles på tilsvarende måte som i eksempel 2 35o mg 18- methy1-19-nor-A^-pregnen-17a-ol-3,20-dion-17a-capronat. Smeltepunkt 109-110°C (ether/pentan); UV (methanol): £^39 = 17 300. ;Eksempel 6. ;Gjennom en opplosning av 14 g 20,20-ethylendioxy-l8-methy1-19-nor-A"'"' -pre<g>natrien-3,17ct-diol-3-methylether og 75 g lithiumklorid i 15000 ml methylamin ledes i 12 timer under tilbake-lbpskjbling og under omroring en likestrom på 1,5 A og 35-<*>+0 V. Av-standen mellom elektrodene er 12,5 cm. Etter endt reaksjon tilsettes 50 ml methanol, hvoretter methylaminet avdestilleres■og substansen utfelles i vann. Utfeiningen frafiltreres og tas opp i methylenklorid. Den organiske fase vaskes til noytral reaksjon med vann og inndampes i vakuum. Residuet opplbses i en blanding av <>>+00 ml methanol og 80 ml methylenklorid, og oppløsningen tilsettes 60. ml. kons. saltsyre og 100 ml isvann og omrores i 2 timer ved <1>+0°C. Deretter fortynnes blandingen med vann, substansen ekstraheres med methylenklorid, og den organiske fase vaskes noytral med vann, natriumbi-earbonatopplbsning og deretter på ny med vann og torres over natriumsulfat. Oppløsningen inndampes til tbrrhet. Residuet omkrystalliseres fra ethylacetat over carbon. Det erholdes 6,3 og 18-methyl-19-nor-A<L>+--pregnen-17a-ol-3,20-dion. Smeltepunkt 216°C; UV (methanol): <£>2^0 <=> ^ 600. (methanol): ^40 = 1^ 10°*;Example 3 <->■<-->;A mixture of 5 g of ltt-methyl-19-nor-A^-pregnen-17a-pl-3,20- dione-17-acetate and 10 g of chloranil in 125 ml of ethyl acetate and 25 ml of glacial acetic acid I, heated at the boiling point for 20 hours under a nitrogen atmosphere.After cooling, the mixture is diluted with ether and it is terred with V"4jÉB g^Bgar-then it is washed with 1%-ig caustic soda until the organic phase has become colorless. After drying over sodium sulfate and removal of the solvent, the residue is chromatographed over silica gel. 2.3 g of ltt-methyl-19-npr-A^'<6->pregnadien-1 are retained -7a-ol-3v20-df^rl7-acetate. 'Illist f ;Example 4 ;To a solution of 4.7 g of 18-methyl-19-nor-A^-pregnen-1Jg-ol-3,20-dione -17-acetate in 25 ml abs. dioxane is added with stirring, 4 ml ethyl orthoformic acid and 1 ml of a solution of 2.5 ml conc. sulfuric acid in JO ml abs. dioxane. After 30 minutes of stirring at room temperature, the reaction mixture is added with 1 ml abs. pyridine, after which the mixture is evaporated in a rotary evaporates and the residue is triturated with acid-free methanol. The product is purified by recrystallization from methanol/methylene chloride. 4 g of 1S-methyl-19-nor-N-[alpha]-pregnadiene-3,17a-diol-20-one-3-ethylether-17a-acetate are obtained. A mixture of 86 ml of acetone, 0.6 ml of pyridine, 2.7 g of sodium acetate, 27 ml of water and 4,5 9 18-methyl-19-nor-αJ'-pregnadiene-3,17a-diol-20 -one-3-ethylether-17a-acetate is cooled to -5°C and, over the course of 20 minutes and thorough stirring, 2.2 g of N-bromosuccinimide and 2.7 ml of glacial acetic acid are added. After stirring for 1 1/2 hours while maintaining the temperature in the range from 0° to -5°C, it is extracted with ether, after which the organic phase is washed to a neutral reaction with water and dried. The solution of 6a-bromo-18-methyl-19-nor-A^-pregnen-1/a-ol-3,20-dione-17-acetate in ether is evaporated in vacuum to a small volume at a temperature below 20°C , after which 70 ml of dimethylformamide, 15 g of calcium carbonate and 7 9 of lithium bromide are added. Nitrogen is blown through the solution^ and this is heated somewhat to drive off residues of ether. Finally, the mixture is heated for half an hour at 120°C with stirring and under a nitrogen atmosphere. The calcium carbonate is then filtered off hot using a sintered glass filter, after which the solid residue is washed with hot dimethylformamide and the filtrates are combined and poured into ice water. After neutralization of the water sweep with sulfuric acid, the precipitate is filtered off. The residue is dissolved in methylene chloride and the solution is washed with water and dried. After distilling off the solvent, the crude product obtained is chromatographed over silica gel. 2.5 g of lb-methy 1-19-nor-H 3 -pregnadien-17a-ol-3,2o-dione-17-acetate are obtained. ;Example 5 ;From 700 ml of 18-methyl-19-nor-A^-pregnen-17a-ol-3,20-dione, 0.456 ml of caproic acid and 0.42 ml of trifluoroacetic anhydride in 2.5 ml. abs. benzene is prepared in a similar way as in example 2 350 mg 18-methyl-19-nor-α-pregnen-17a-ol-3,20-dione-17a-capronate. Melting point 109-110°C (ether/pentane); UV (methanol): £^39 = 17 300. ;Example 6. ;Through a solution of 14 g of 20,20-ethylenedioxy-18-methy1-19-nor-A"'"' -pre<g>natriene-3 ,17ct-diol-3-methylether and 75 g of lithium chloride in 15,000 ml of methylamine are passed for 12 hours under reflux and with stirring a direct current of 1.5 A and 35-<*>+0 V. The distance between the electrodes is 12.5 cm. After the reaction is complete, 50 ml of methanol is added, after which the methylamine is distilled off and the substance is precipitated in water. The skimming is filtered off and taken up in methylene chloride. The organic phase is washed to a neutral reaction with water and evaporated in a vacuum. The residue is dissolved in a mixture of <>>+00 ml of methanol and 80 ml of methylene chloride, and the solution is added to 60 ml. conc. hydrochloric acid and 100 ml of ice water and stirred for 2 hours at <1>+0°C. The mixture is then diluted with water, the substance is extracted with methylene chloride, and the organic phase is washed neutrally with water, sodium bicarbonate solution and then again with water and dried over sodium sulfate. The solution is evaporated to dryness. The residue is recrystallized from ethyl acetate over carbon. 6,3 and 18-methyl-19-nor-A<L>+--pregnen-17a-ol-3,20-dione are obtained. Melting point 216°C; UV (methanol): <£>2^0 <=> ^ 600.

Claims (3)

1. Analogifremgangsmåte ved fremstilling av farmakologisk aktive l8-methyl-19-nor-17ct-hydroxyprogesteroner og deres -17-estere av1. Analogous method for the production of pharmacologically active 18-methyl-19-nor-17ct-hydroxyprogesterones and their -17-esters of hvor R betegner hydrogen eller en acylrest med 1-11 carbonatomer i esterresten og C> C„ betegner en enkelt eller dobbelt carbon-carbon-binding, karakter_isert ved at 18-methyl-19-nor-A<1>'^'^(<10>)-pregnatrien-3,17a-diol-20-on-3-alkylether-20-ketal reduseres etter Birch i flytende ammoniakk eller elektrolytisk, i organisk løsningsmiddel og at primærproduktet hydrolyseres i surt miljo og at de.t således erholdte l8-methyl-19-nor-17a-hydroxyproges-teron eventuelt omsettes med en onsket syre eller et reaktivt syrederivat til -17-ester, og at det om bnskes innfores en dobbeltbind ing i 6,7-stillingen. where R denotes hydrogen or an acyl residue with 1-11 carbon atoms in the ester residue and C> C„ denotes a single or double carbon-carbon bond, characterized in that 18-methyl-19-nor-A<1>'^'^( <10>)-pregnatriene-3,17a-diol-20-one-3-alkylether-20-ketal is reduced according to Birch in liquid ammonia or electrolytically, in an organic solvent and that the primary product is hydrolyzed in an acidic environment and that the thus obtained 18-methyl-19-nor-17a-hydroxyprogesterone is optionally reacted with a desired acid or a reactive acid derivative to -17-ester, and that, if desired, a double bond is introduced in the 6,7 position. 2. Analogifremgangsmåte ifolge krav 1, karakterisert ved at 20,20,ethylenoxy-l8-methyl-19-nor-A1'^' ^10')-pregnatrien-3,17a-diol-3-methylether reduseres etter 3irch i flytende ammoniakk, hvoretter reaksjonsproduktet hydrolyseres i surt miljo. 2. Analogous method according to claim 1, characterized in that 20,20,ethyleneoxy-18-methyl-19-nor-Al'^' (10')-pregnatriene-3,17a-diol-3-methylether is reduced after 3irch in liquid ammonia , after which the reaction product is hydrolysed in an acidic environment. 3. Analogifremgangsmåte ifolge krav 1, karakterisert ved at l8-methyl-19-nor-17a-hydroxyprogesteron omsettes med iseddik i nærvær av trifluoreddiksyreanhydrid. h. Analogifremgangsmåte ifolge krav 1, karakterisert ved at l8-methyl-19-nor-17a-hydroxyprogesteron omsettes med capronsyre i nærvær av trifluoreddiksyreanhydrid.3. Analogous method according to claim 1, characterized in that 18-methyl-19-nor-17a-hydroxyprogesterone is reacted with glacial acetic acid in the presence of trifluoroacetic anhydride. h. Analogous method according to claim 1, characterized in that 18-methyl-19-nor-17a-hydroxyprogesterone is reacted with caproic acid in the presence of trifluoroacetic anhydride.
NO01721/68A 1967-05-05 1968-05-03 NO127194B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESC040657 1967-05-05

Publications (1)

Publication Number Publication Date
NO127194B true NO127194B (en) 1973-05-21

Family

ID=7435799

Family Applications (1)

Application Number Title Priority Date Filing Date
NO01721/68A NO127194B (en) 1967-05-05 1968-05-03

Country Status (13)

Country Link
AT (1) AT279819B (en)
BE (1) BE714593A (en)
CA (1) CA923891A (en)
CH (2) CH581150A5 (en)
CS (1) CS150217B2 (en)
DK (1) DK119976B (en)
ES (1) ES351661A1 (en)
FI (1) FI45175C (en)
FR (2) FR1581520A (en)
GB (1) GB1226356A (en)
NL (1) NL160276C (en)
NO (1) NO127194B (en)
SE (1) SE335856B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5655400A (en) * 1979-10-12 1981-05-15 Mitsubishi Chem Ind Ltd Improved preparation process of 4,6-dien-3-one steroid
HU216828B (en) * 1995-12-22 1999-09-28 Richter Gedeon Vegyészeti Gyár Rt. Steroids, process for producing them, pharmaceutical compositions containing them and their intermediates
HUP0301332A3 (en) * 2003-05-14 2006-04-28 Richter Gedeon Vegyeszet New mono-and bismethylene steroid derivatives and process for their synthesis and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FI45175B (en) 1971-12-31
GB1226356A (en) 1971-03-24
FR1581520A (en) 1969-09-19
DE1643020A1 (en) 1971-04-15
NL6806348A (en) 1968-11-06
AT279819B (en) 1970-03-25
NL160276B (en) 1979-05-15
SE335856B (en) 1971-06-14
CA923891A (en) 1973-04-03
NL160276C (en) 1979-10-15
FR8084M (en) 1970-07-20
CH581150A5 (en) 1976-10-29
ES351661A1 (en) 1969-06-01
DK119976B (en) 1971-03-22
FI45175C (en) 1972-04-10
CH563408A5 (en) 1975-06-30
CS150217B2 (en) 1973-09-04
BE714593A (en) 1968-11-04

Similar Documents

Publication Publication Date Title
NO167495B (en) PROCEDURE AND APPARATUS FOR SEPARATING A CASE.
NO124646B (en)
US3965128A (en) 6β,7β-Epoxy-1α,2α-methylen-D-homo-4-pregnen-3,20-diones
US3682983A (en) Preparation of {66 {11 {11 -17 ethinyl steroids
US4119625A (en) Process for the manufacture of steroid carboxylic acids and the esters thereof
US2878267A (en) 19-nor-steroid compounds and process for the preparation thereof
NO127194B (en)
US3328432A (en) Novel progesterone derivatives
US2777843A (en) Preparation of 4-pregnen-17alpha-ol-3, 20-dione
US3483226A (en) 16-oxa and 17 - oxa - d - homoestra - 1,3,5(10)-trien-3-ols and d-nor-seco-diols corresponding,ethers and esters thereof
US3639392A (en) Cardioactive oxido-bufatrienolides
HU177452B (en) Process for preparing new d-homo-steroids
NO124598B (en)
US2562030A (en) Production of 17-hydroxy 20-keto steroid compounds
US2907758A (en) 3, 5-cyclo-18, 20-epoxypregnane derivatives
US3781311A (en) Novel preparation of trienic steroids
US3067213A (en) 6, 16-dihalo-17-acyloxy-progesterones
US3164616A (en) Process for preparing delta11-steroid compounds
US3767685A (en) Novel 11beta-halo-steroids of the oestrane series
US2598648A (en) Process for the production of compounds of the androstane series
Batres et al. Steroids. CLVII. 1 6-Aminoandrostanes
US3039528A (en) Intermediates in the preparation of aldosterone antagonists
US2744109A (en) 3-ethylene mercaptoles of 21-hydroxy-4-pregnene-3, 20-dione, its 17-hydroxy derivative and esters thereof
US3063985A (en) Cyclopentanophenanthrene compounds and process
US3037034A (en) Process for the preparation of esters of corticosteroids